YAP1 and cancer: We found a trend toward lower SLC35B2 expression in YAP5SA cell lines compared to controls, indicating that SLC35B2 might not be a direct YAP1 target and molecular regulators independent from YAP1/TAZ might drive SLC35B2 expression in cancer (Fig. 4e).